Diabetic foot infections: A need for innovative assessments

Timothy K. Fisher, Randall Wolcott, Donna M. Wolk, Manish Bharara, Heather R. Kimbriel, David G. Armstrong

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Abstract

Foot wounds are the most common diabetes-related cause of hospitalization and frequently result in amputation. Although generally diagnosed clinically based on signs and symptoms of inflammation, empirical antibiotic treatment should be based on tissue cultures until resolution of infection. Advances in molecular detection over the past decade, including rapid chromogenic agar and real-time polymerase chain reaction, have improved diagnostic capabilities. However, chronic wounds may host biofilm bacteria not adequately detected by current microbiological testing. Enhanced DNA testing is required to identify these pathogens as well as evolving and previously underdiagnosed bacteria. Two options, nucleic acid fluorescent in situ hybridization and rDNA sequencing, are on the horizon for clinical use. Wound biofilms also necessitate more complex clinical management including debridement, augmenting host defenses, suppression of biofilms, and wound closure. Adopting these advances in diagnosis and treatment may help with overall prognosis and reduce health care costs.

Original languageEnglish (US)
Pages (from-to)31-36
Number of pages6
JournalInternational Journal of Lower Extremity Wounds
Volume9
Issue number1
DOIs
StatePublished - Mar 1 2010

Keywords

  • Detection
  • Diabetic foot infection
  • Innovations

ASJC Scopus subject areas

  • Surgery

Fingerprint Dive into the research topics of 'Diabetic foot infections: A need for innovative assessments'. Together they form a unique fingerprint.

Cite this